The Latest Cardiac and Vascular News
SAN FRANCISCO, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) — InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today provided a corporate update highlighting fundraising and clinical development milestones. These achievements have contributed to the continued successful development of its lead clinical program, while […]
NEW HOPE, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing advanced therapeutic solutions to address major unmet medical needs, announced today that Professor Petr Neuzil, M.D., Head of the Department of Cardiology of Na Homolce Hospital in Prague, Czech […]
SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, a medical device company developing next generation ECG devices using continuous wavelet transform (CWT) signal processing, is proud to announce its participation as an exhibitor at the upcoming 2018 Scientific Sessions of the American Heart Association (AHA). The AHA Congress will take place November 10-12, 2018 at […]
DENVER, Nov. 6, 2018 /PRNewswire/ — Medical device startup, HeartHero has signed an agreement to license VivaQuant MDSP cardiac arrhythmia detection technology for its portable AED. HeartHero will leverage VivaQuant’s ground breaking arrhythmia technology to detect fatal heart rhythms and provide crucial lifesaving technology. In September, HeartHero won the ACEP InnovatED competition for most innovative medical device […]
WESTMINSTER, Colo., Nov. 05, 2018 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that data from the Atrial Fibrillation Burden (AFB) substudy of the Phase 2B GENETIC-AF clinical trial have been selected for a poster presentation […]
COPENHAGEN, Denmark, November 5, 2018 /PRNewswire/ — – Phase 1 data show favourable safety profile – Data support further development of AP30663 for cardioversion therapy Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, announces positive results from the Phase 1 clinical trial of its […]
KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable cardiac biosensors and clinical diagnostic software systems featuring proprietary automated data analysis algorithms, announced today it has partnered with VivoSense®, a leader in integration and specialized analysis of wearable sensor data for research and clinical trials. Together, both companies will […]
Santa Monica, CA, Oct. 29, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, announced today that it will be presenting […]
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, is proud to announce the Arrow AC3 Optimus Intra-Aortic Balloon Pump, has been selected as the bronze winner in the cardiovascular device category of the 20th annual Medical Design Excellence Awards competition. The […]
VANCOUVER, Oct. 29, 2018 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV /TSX: CORV), a specialty pharmaceutical company focused on providing high-quality brands to acute care physicians and patients, today announced that it has received independent regulatory and legal opinions that Brinavess® (vernakalant hydrochloride, IV) may qualify for up to a 5-year patent extension from the U.S. […]
